Risk Factors Affecting Ischemic Stroke: A Potential Side Effect of Antihypertensive Drugs — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Risk Factors Affecting Ischemic Stroke: A Potential Side Effect of Antihypertensive Drugs
Graduate School of Engineering, University of Tokyo, and Research Center for Health Policy and Economics, Hitotsubashi University, Hitotsubashi, Japan
1 Graduate School of Engineering, University of Tokyo, and Research Center for Health Policy and Economics, Hitotsubashi University, Hitotsubashi, Japan
Background: Stroke is a worldwide health problem, the world’s second-leading cause of death and third-leading cause of disability. Currently, the majority of stroke patients are ischemic stroke patients. It is necessary to evaluate risk factors to prevent ischemic stroke. Data and Methods: The risk factors for stroke in the previous fiscal year were analyzed. They were divided into nonmodifiable and modifiable factors. The probit and ordered probit models were used in the study, with 59341 and 50542 observations used in the estimation of the models, respectively. Results: Among the nonmodifiable factors, age, gender and cerebrovascular disease history are important risk factors. The history of cerebrovascular diseases is considered to be an especially important factor. Among the modifiable factors, taking antihypertensive drugs and recent large weight change are negative risk factors; however, sleeping well significantly reduces the probability of ischemic stroke. Conclusion: It is very important to ensure that medical personnel know a patient’s history of cerebrovascular diseases for proper treatments. Ischemic stroke might be considered an important side effect of antihypertensive drugs. Limitations: The dataset was observatory. There are various types of antihypertension drugs, and their effects are not analyzed.
Johnson, W., Onuma, O., Owolabi, M., et al. (2016) Stroke: A Global Response Is Needed. Bulletin of the World Health Organization, 94, 634-634A. https://doi.org/10.2471/BLT.16.181636
Centers for Diseases Control and Prevention (CDC) (2020) About Stroke. https://www.cdc.gov/stroke/about.htm
World Health Organization, WHO (2020) Global Burden of Stroke. The Atlas of Heart Disease and Stroke. https://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf?ua=1/
WHO (2020) Top 10 Causes of Death. https://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/
World Stroke Organization, WSO (2018) World Health Organization Annual Report 2018.
Lindsay, M.P., Norrving, B., Sacco, R.L., et al. (2019) World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. International Journal of Stroke, 14, 806-817. https://doi.org/10.1177/1747493019881353
Virani, S.S., Alonso, A., Benjamin, E.J., et al. (2020) Heart Disease and Stroke Statistics-2020 Update, A Report from the American Heart Association. Circulation, 141, e139-e596. https://doi.org/10.1161/CIR.0000000000000757
Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al. (2017) Heart Disease and Stroke Statistics-2017 Update, a Report from the American Heart Association. Circulation, 135, e146-e603. https://doi.org/10.1161/CIR.0000000000000485
Heron, M. (2019) Deaths: Final Data for 2017. National Vital Statistics Reports Volume 68, Number 9, National Center for Health Statistics, CDC. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_06-508.pdf
Thrift, A.G., Thayabaranathan, T. and Howard, G. (2017) Global Stroke Statistics. International Journal of Stroke, 12, 13-32. https://doi.org/10.1177/1747493016676285
CDC (2020) Types of Stroke. https://www.cdc.gov/stroke/types_of_stroke.htm
Mozzafarian, D., Benjamin, E.J., Go, A.S., et al. (2016) Heart Disease and Stroke Statistics—2016 Update: A Report from the American Heart Association. Circulation, 133, e38-360. https://doi.org/10.1161/CIR.0000000000000350
Ministry of Health, Labor and Welfare (2019) Heisei 29 nendo kokumin iryouhi no gaikyou (Summary of National Medical Expenditures in Fiscal Year 2017) (In Japanese).
Ministry of Health, Labor and Welfare (2019) Heisei 30 nen jinnkou soutai toukei no gaikyou (Summary of Demographic Statistics in 2018) (In Japanese).
Ministry of Health, Labor and Welfare (2019) Heisei 29 nen kanja chousa no gaikyou (Summary of the Patient Survey in 2017) (In Japanese).
Powers, W.J., Rabinstein, A.A., Ackerson, T., et al. (On Behalf of the American Heart Association Stroke Council) (2018) Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 49, e46-e99. https://doi.org/10.1161/STR.0000000000000172
Powers, W.J., Rabinstein, A.A., Ackerson, T., et al. (On Behalf of the American Heart Association Stroke Council) (2019) Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 50, e344-e418. https://doi.org/10.1161/STR.0000000000000211
Ike, P., Borlongan, C., Shen, G., et al. (2017) et al. “Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need. Journal of Stroke, 19, 50-60. https://doi.org/10.5853/jos.2016.01515
Saver, J.L., Goyal, M., van der Lugt, A., et al. (2016) Time to Treatment with Endovascular Thrombectomy and Outcomes from Ischemic Stroke: A Meta-Analysis. Journal of American Medical Association, 316, 1279-1288. https://doi.org/10.1001/jama.2016.13647
Hendén, P.L., Rentzos, A., Karlsson, J.E., et al. (2017) General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke the An Stroke Trial (Anesthesia During Stroke). Stroke, 48, 1601-1607. https://doi.org/10.1161/STROKEAHA.117.016554
Hu, Y.C. and Stiefel, M.F. (2016) Force and Aspiration Analysis of the ADAPT Technique in Acute Ischemic Stroke Treatment. Journal of NeuroIntervent Surgery, 8, 244-246. https://doi.org/10.1136/neurintsurg-2014-011563
Balami, J.S., White, P.M., McMeekin, P., et al. (2018) Complications of Endovascular Treatment for Acute Ischemic Stroke: Prevention and Management. International of Stroke, 13, 362-373. https://doi.org/10.1177/1747493017743051
Vargas, J., Spiotta, A., Fargen, K., Turner, R., et al. (2017) Long Term Experience Using the ADAPT Technique for the Treatment of Acute Ischemic Stroke. Journal of NeuroIntervent Surgery, 9, 437-441. https://doi.org/10.1136/neurintsurg-2015-012211
Xian, Y., O’Brien, E.C., Liang, L., et al. (2018) Association of Preceding Antithrombotic Treatment with Acute Ischemic Stroke Severity and in-Hospital Outcomes among Patients with a Trial Fibrillation. Journal of American Medical Association, 317, 1057-1067. https://doi.org/10.1001/jama.2017.1371
Paul, R.A.G. and McMullen, W. (2017) Neuroprotection in the Treatment of Acute Ischemic Stroke. Progress in Cardiovascular Diseases, 59, 542-548. https://doi.org/10.1016/j.pcad.2017.04.005
Feng, D., Wang, B. and Wang, L. (2017) Pre-Ischemia Melatonin Treatment Alleviated Acute Neuronal Injury after Ischemic Stroke by Inhibiting Endoplasmic Reticulum Stress-Dependent Autophagy via PERK and IRE1 Signalings. Journal of Pineal Research, 62, e12395. https://doi.org/10.1111/jpi.12395
Patel, V.P. and Heit, J.J. (2017) Ischemic Stroke Treatment Trials: Neuroimaging Advancements and Implications. Topics in Magnetic Resonance Imaging, 26, 133-139. https://doi.org/10.1097/RMR.0000000000000118
Hassan, A.E., Shariff, U., Saver, J.L., Goyal, M., et al. (2019) Impact of Procedural Time on Clinical and Angiographic Outcomes in patients with Acute Ischemic Stroke Receiving Endovascular Treatment. Journal of NeuroIntervent Surgery, 11, 984-988. https://doi.org/10.1136/neurintsurg-2018-014576
Jahan, R., Saver, J.L., Schwamm, L.H., et al. (2019) Association between Time to Treatment with Endovascular Reperfusion Therapy and Outcomes in Patients with Acute Ischemic Stroke Treated in Clinical Practice. Journal of American Medical Association, 322, 252-263. https://doi.org/10.1001/jama.2019.8286
Weber, R., Krogias, C., Eyding, J., et al. (2019) Age and Sex Differences in Ischemic Stroke Treatment in a Nationwide Analysis of 1.11 Million Hospitalized Cases. Stroke, 50, 3494-3502. https://doi.org/10.1161/STROKEAHA.119.026723
Nie, J. and Yang, X. (2017) Modulation of Synaptic Plasticity by Exercise Training as a Basis for Ischemic Stroke Rehabilitation. Cellular and Molecular Neurobiology, 37, 5-16. https://doi.org/10.1007/s10571-016-0348-1
Civelek, G.M., Atalay, A. and Turhan, N. (2016) Medical Complications Experienced by First-Time Ischemic Stroke Patients during Inpatient, Tertiary Level Stroke Rehabilitation. The Journal of Physical Therapy Science, 28, 382-391. https://doi.org/10.1589/jpts.28.382
Lia F., Pendy, J.T., Dingb, J.N., et al. (2017) Exercise Rehabilitation Immediately Following Ischemic Stroke Exacerbates Inflammatory Injury. Neurological Research, 39, 530-537. https://doi.org/10.1080/01616412.2017.1315882
Gabriel-Salazar, M., Morancho, A., Rodriguez, S., et al. (2018) Importance of Angiogenin and Endothelial Progenitor Cells after Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia. Frontiers in Neurology, 9, Article No. 508. https://doi.org/10.3389/fneur.2018.00508
Forti, P., Maioli, F., Magni, E., et al. (2018) Risk of Exclusion from Stroke Rehabilitation in the Oldest Old. Archives of Physical Medicine and Rehabilitation, 99, 477-483. https://doi.org/10.1016/j.apmr.2017.08.469
Arnao, V., Riolo, M., Carduccioet, F., et al. (2019) Effects of Transcranial Random Noise Stimulation Combined with Graded Repetitive Arm Supplementary Program (GRASP) on Motor Rehabilitation of the Upper Limb in Subacute Ischemic Stroke Patients: A Randomized Pilot Study. Journal of Neural Transmission, 126, 1701-1706. https://doi.org/10.1007/s00702-019-02087-9
Prasetyanto, D. and Yona, S. (2019) Meridian Acupuncture in Stroke Rehabilitation: A Literature Review. International Journal of Nursing and Health Services, 2, 48-54. https://doi.org/10.35654/ijnhs.v2i2.100
Scrutinio, D., Lanzillo, B. and Guida, P. (2020) Association between Malnutrition and Outcomes in Patients with Severe Ischemic Stroke Undergoing Rehabilitation. Archives of Physical Medicine and Rehabilitation. https://doi.org/10.1016/j.apmr.2019.11.012
Boehme, A.K., Esenwa, C. and Elkind, M. S.V. (2017) Stroke Risk Factors, Genetics, and Prevention. Circulation Research, 120, 472-495. https://doi.org/10.1161/CIRCRESAHA.116.308398
American Stroke Association (ASA) (2020) Stroke Risk Factors Not within Your Control. https://www.stroke.org/en/about-stroke/stroke-risk-factors/stroke-risk-factors-not-within -your-control?
ASA (2018) Stroke Risk Factors You Can Control, Treat and Improve. https://www.stroke.org/en/about-stroke/stroke-risk-factors/stroke-risk-factors-you-can-control -treat-and-improve
Allen, C.L. and Bayraktutan, U. (2008) Risk Factors for Ischaemic Stroke. International Journal of Stroke, 3, 105-116. https://doi.org/10.1111/j.1747-4949.2008.00187.x
Fahimfar, N., Khalili, D., Mohebi, R., et al. (2012) Risk Factors for Ischemic Stroke; Results from 9 Years of Follow-up in a Population Based Cohort of Iran. BMC Neurology, 12, 117. https://doi.org/10.1186/1471-2377-12-117
Ohira, T., Shahar, E., Chambless, L.E., et al. (2016) Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study. Stroke, 37, 2493-2498. https://doi.org/10.1161/01.STR.0000239694.19359.88
Bang, O.Y., Ovbiagele, B. and Kim, J.S. (2015) Nontraditional Risk Factors for Ischemic Stroke: An Update. Stroke, 46, 3571-3578. https://doi.org/10.1161/STROKEAHA.115.010954
Japanese Law Translation (2009) Industrial Safety and Health Act. http://www.japaneselawtranslation.go.jp/law/detail/?id=1926&vm=&re=
Ministry of Health, Labour and Welfare (2018) Shakai hokenn hyoushou you shippei bunrui (Disease Classification Tables for the Social Insurances) (In Japanese). https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryouhoken/database/ hokensippei.html
Amemiya, T. (1985) Advanced Econometrics. Harvard University Press, Cambridge, MA.
Whelton, P.K., Carey, R.M., Arrow, W.S., et al. (2018) 2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115. https://doi.org/10.1161/HYP.0000000000000075
American Academy of Family Physicians (AAFP) (2017) AAFP Decides to Not Endorse AHA/ACC Hypertension Guideline, Academy Continues to Endorse JNC8 Guideline. AAFP News. https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html
Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal, 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
Nerenberg, K.A., Zarnke, K.B., Leung, A.A., et al. (2018) Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal of Cardiology, 34, 506-525. https://doi.org/10.1016/j.cjca.2018.02.022
Goupil, R., Lamarre-Cliché, M., Vallee, M., et al. (2018) The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications. Canadian Journal of Cardiology, 34, 665-669. https://doi.org/10.1016/j.cjca.2018.01.011
American Diabetes Association (2018) Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018. Diabetes Care, 41, S86-S104. https://doi.org/10.2337/dc18-S009
Hirawa, N., Umemura, S. and Ito, S. (2019) Viewpoint on Guidelines for Treatment of Hypertension in Japan. Circulation Research, 124, 981-983. https://doi.org/10.1161/CIRCRESAHA.119.314991
Wright, J.T., Williamson, J.D., Whelton, P.K., et al. (SPRINT Research Group) (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine, 373, 2103-2116. https://doi.org/10.1056/NEJMoa1511939
Nawata, K., Sekizawa, Y. and Kimura, M. (2018) Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials. Health, 10, 587-603. https://doi.org/10.4236/health.2018.105047
MedlinePlus (2018) High Blood Pressure Medicines. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/007484.htm
Laurent, S. (2017) Antihypertensive Drugs. Pharmacological Research, 124, 116-125. https://doi.org/10.1016/j.phrs.2017.07.026
Tedla, Y.G. and Bautista, L.E. (2016) Drug Side Effect Symptoms and Adherence to Antihypertensive Medication. American Journal of Hypertension, 29, 772-779. https://doi.org/10.1093/ajh/hpv185
Boutari, C., Stavropoulos, K., Imprialos, K.P., et al. (2016) Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Non Adherence? American Journal of Hypertension, 29, 662. https://doi.org/10.1093/ajh/hpw024
WebMed(2018) Side Effects of High Blood Pressure Medications. https://www.webmd.com/hypertension-high-blood-pressure/guide/side-effects-high-blood -pressure-medications#1
Ogbru, O. and Marks, J.W. (2019) High Blood Pressure Drugs Side Effects, Types, Uses, and List of Names. MedicineNet. https://www.medicinenet.com/high_blood_pressure_medication/article.htm#what_are_the _common_types_of_high_blood_pressure_hypertension_medications
Harvard Heath Publishing (2017) Controlling Blood Pressure with Fewer Side Effects. Harvard Medical School. https://www.health.harvard.edu/heart-health/controlling-blood-pressure-with-fewer-side-effects
Li, W., Moore, M.J., Vasilieva, N., et al. (2003) Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Letters to Nature. Nature, 426, 450-454. https://doi.org/10.1038/nature02145
Kuba, K., Imai, Y., Rao, S., et al. (2005) A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury. Nature Medicine, 11, 875-879. https://doi.org/10.1038/nm1267
Bozkurt, B., Kovacs, R. and Harrington, B. (2020) HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. ACC News Story, American College of Cardiology. https://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19
Muntner, P., Carey, R.M., Gidding, S., et al. (2018) Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Journal of the American College of Cardiology, 71, 109-118. https://doi.org/10.1016/j.jacc.2017.10.073
Nawata, K. and Kimura, M. (2018) Does High Systolic Blood Pressure Truly Increase Medical Expenditure? An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline. Health, 10, 1044-1065. https://doi.org/10.4236/health.2018.108079
Nawata, K. and Kimura, M. (2018) Empirical Studies of Effects of High Blood Pressure on Medical Costs and Heart Disease: Is the 2017 ACC/AHA Guideline Supported by Enough Evidence? Health, 10, 1498-1519. https://doi.org/10.4236/health.2018.1011115
Nawata, K., Sugano, H. and Kimura, M. (2019) An Analysis of the Effects of Blood Pressure and Antihypertensive Drugs on Heart Disease. Health, 11, 792-816. https://doi.org/10.4236/health.2019.116064